Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's Disease.
Karim ArafahMark KriegsmannMarcus RennerFelix LasitschkaMargaux FresnaisKatharina KriegsmannMoritz von WinterfeldBenjamin GoeppertJörg KriegsmannRita CasadonteDaniel N KazdalPhilippe BuletRémi LonguespéePublished in: Proteomics. Clinical applications (2020)
Overall, the results suggest that microproteomics is an adequate tool to highlight protein patterns in IBD. IHC and digital pathology might support future differential diagnosis of UC and CD.